149 related articles for article (PubMed ID: 19393131)
1. Inhibition of CD44 expression by small interfering RNA to suppress the growth and metastasis of ovarian cancer cells in vitro and in vivo.
Li CZ; Liu B; Wen ZQ; Li HY
Folia Biol (Praha); 2008; 54(6):180-6. PubMed ID: 19393131
[TBL] [Abstract][Full Text] [Related]
2. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
3. Efficient inhibition of intraperitoneal human ovarian cancer growth by short hairpin RNA targeting CD44.
Zou L; Yi T; Song X; Li S; Wei Y; Zhao X
Neoplasma; 2014; 61(3):274-82. PubMed ID: 24824928
[TBL] [Abstract][Full Text] [Related]
4. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of small interfering RNA targeting insulin-like growth factor-I receptor in ovarian cancer OVCAR3 cells.
An Y; Cai Y; Guan Y; Cai L; Yang Y; Feng X; Zheng J
Cancer Biother Radiopharm; 2010 Oct; 25(5):545-52. PubMed ID: 20950153
[TBL] [Abstract][Full Text] [Related]
6. MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.
Yang X; Iyer AK; Singh A; Choy E; Hornicek FJ; Amiji MM; Duan Z
Sci Rep; 2015 Feb; 5():8509. PubMed ID: 25687880
[TBL] [Abstract][Full Text] [Related]
7. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
Liu YL; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
[TBL] [Abstract][Full Text] [Related]
8. Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
Nakamura K; Sawada K; Kinose Y; Yoshimura A; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Morishige KI; Kurachi H; Lengyel E; Kimura T
Mol Cancer Res; 2017 Jan; 15(1):78-92. PubMed ID: 27758876
[TBL] [Abstract][Full Text] [Related]
9. Introduction of antisense CD44S CDNA down-regulates expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma cells.
Harada N; Mizoi T; Kinouchi M; Hoshi K; Ishii S; Shiiba K; Sasaki I; Matsuno S
Int J Cancer; 2001 Jan; 91(1):67-75. PubMed ID: 11149422
[TBL] [Abstract][Full Text] [Related]
10. Gab2 promotes cancer stem cell like properties and metastatic growth of ovarian cancer via downregulation of miR-200c.
Fang Z; Li T; Chen W; Wu D; Qin Y; Liu M; Wu G; He L; Li H; Gu H
Exp Cell Res; 2019 Sep; 382(1):111462. PubMed ID: 31194976
[TBL] [Abstract][Full Text] [Related]
11. A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.
Yao H; Sun L; Li J; Zhou X; Li R; Shao R; Zhang Y; Li L
Int J Nanomedicine; 2020; 15():7013-7034. PubMed ID: 33061365
[TBL] [Abstract][Full Text] [Related]
12. Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy.
Subramaniam V; Vincent IR; Gilakjan M; Jothy S
Exp Mol Pathol; 2007 Dec; 83(3):332-40. PubMed ID: 17945212
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer.
Gao Y; Foster R; Yang X; Feng Y; Shen JK; Mankin HJ; Hornicek FJ; Amiji MM; Duan Z
Oncotarget; 2015 Apr; 6(11):9313-26. PubMed ID: 25823654
[TBL] [Abstract][Full Text] [Related]
14. [Effect and mechanism of gene therapy of lentivirus mediated RhoA shRNA on ovarian cancer xenograft in vivo].
Jiang WY; Kang JL; Wang XX; Yang WJ; Nie ML; Zhou C
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):778-83. PubMed ID: 24406137
[TBL] [Abstract][Full Text] [Related]
15. Binding of ovarian cancer cells to immobilized hyaluronic acid.
Catterall JB; Gardner MJ; Jones LM; Turner GA
Glycoconj J; 1997 Aug; 14(5):647-9. PubMed ID: 9298699
[TBL] [Abstract][Full Text] [Related]
16. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
[TBL] [Abstract][Full Text] [Related]
17. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
[TBL] [Abstract][Full Text] [Related]
18. [Effect of semaphorin4D gene silencing on malignant behavior of human ovarian cancer SKOV3 cells].
Chen Y; Zhang L; Wu HJ; Liu WX; Hao Q
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):324-30. PubMed ID: 21875458
[TBL] [Abstract][Full Text] [Related]
19. TPX2 siRNA regulates growth and invasion of esophageal cancer cells.
Liu HC; Zhang GH; Liu YH; Wang P; Ma JF; Su LS; Li SL; Zhang L; Liu JW
Biomed Pharmacother; 2014 Sep; 68(7):833-9. PubMed ID: 25239289
[TBL] [Abstract][Full Text] [Related]
20. The homeoprotein DLX4 stimulates NF-κB activation and CD44-mediated tumor-mesothelial cell interactions in ovarian cancer.
Haria D; Trinh BQ; Ko SY; Barengo N; Liu J; Naora H
Am J Pathol; 2015 Aug; 185(8):2298-308. PubMed ID: 26067154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
